← The SEC Ephemeris: the whole map
GlaxoSmithKline LLC Exdensur lepemokimab-ulaa)
In the graph: all 2 documents (5 pages).
- Application
- BLA 761458
- Ticker
- GlaxoSmithKline LLC
- Product
- Exdensur lepemokimab-ulaa)
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- December 16, 2025 · October 23, 2025
From FDA letters and SEC filings. Not investment or medical advice.